Improving Parental Psychosocial Functioning and Early Developmental Outcomes in Children With Sickle Cell Disease
Primary Purpose
Sickle Cell Disease, Cognitive Ability, General, Psychological Stress
Status
Completed
Phase
Not Applicable
Locations
Jamaica
Study Type
Interventional
Intervention
Play therapy
Problem solving skills
Sponsored by
About this trial
This is an interventional prevention trial for Sickle Cell Disease focused on measuring SCD, early childhood intervention, parental stress, neurocognition
Eligibility Criteria
Inclusion Criteria:
- Infant has sickle cell disease: SS or Sβ0 thalassemia
- Attending Sickle Cell Unit, Jamaica for routine care
Exclusion Criteria:
- None
Sites / Locations
- Sickle Cell Unit, University of West Indies, Mona Campus
Arms of the Study
Arm 1
Arm 2
Arm Type
No Intervention
Experimental
Arm Label
Control
Intervened
Arm Description
The control dyad will receive usual care.
Parents receive training in problem solving skills and play therapy with their infants.
Outcomes
Primary Outcome Measures
Infant's development quotient (Griffiths Developmental Scale)
Griffiths Developmental Scale
Parental stress, depression and coping (Pediatric Inventory for Parents; CES-D; Coping Health Inventory for parents)
Questionnaires to assess: Pediatric Inventory for Parents; CES-D; Coping Health Inventory for parents
Parental problem solving skills (Social Problem Solving Inventory)
Using Social Problem Solving Inventory: Questionnaires
Secondary Outcome Measures
Full Information
NCT ID
NCT02394899
First Posted
February 4, 2015
Last Updated
October 26, 2016
Sponsor
The University of The West Indies
Collaborators
Grand Challenges Canada
1. Study Identification
Unique Protocol Identification Number
NCT02394899
Brief Title
Improving Parental Psychosocial Functioning and Early Developmental Outcomes in Children With Sickle Cell Disease
Official Title
Integrating a Parenting Intervention With Routine Care to Improve Parental Psychosocial Functioning and Early Developmental Outcomes in Children With Sickle Cell Disease
Study Type
Interventional
2. Study Status
Record Verification Date
October 2016
Overall Recruitment Status
Completed
Study Start Date
October 2014 (undefined)
Primary Completion Date
September 2016 (Actual)
Study Completion Date
September 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
The University of The West Indies
Collaborators
Grand Challenges Canada
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
There are all significant risk factors for poor early cognitive development and, as such, neurocognitive deficits have been demonstrated in pre-school children with sickle cell disease (SCD). This project assesses the efficacy of using an evidence-based early stimulation program, combined with components to help parents cope with stress, delivered during six routine monthly clinic visits to parents of children with sickle cell disease. It is hoped that this innovation will improve parental psychological outcomes, as well as child developmental outcomes.
Detailed Description
Children with sickle cell disease (SCD) are at risk of various complications, many of which arise suddenly and call on the problem solving skills of their parents. They are also at risk of neurocognitive delays; these may become evident during the pre-school years. Previous research by this group has demonstrated improved developmental outcomes after parental interventions incorporating play techniques in high risk and healthy pre-school children. The aim of the study is to determine usefulness in children with SCD of similar developmental interventions augmented by lessons in problem solving.
The study is a randomized controlled trial. Parents of all infants with Hb SS (homozygous sickle cell disease) or Sβ0 -thalassemia disease identified by newborn screening during the initial year of the study will be invited to participate. They will be randomized to intervention or control. Parental stress, infant's development and hemoglobin levels will be measured at recruitment and again after six months. The intervention will occur during monthly Penadur (intramuscular Benzathine Penicillin) visits and will include supervised play with their children using an inexpensive toy and participation in solving a problem which may arise as they parent their child with SCD. At the end of the study, all control dyads will also be given the toys used in the intervention. All parents will be given the results of their children's developmental assessments and appropriate referrals made if deficits are identified.
The study is minimal risk. Every effort will be made to maintain patient confidentiality. Respect for, and the maximum protection of the best interests of the research subjects will be maintained.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sickle Cell Disease, Cognitive Ability, General, Psychological Stress, Parenting
Keywords
SCD, early childhood intervention, parental stress, neurocognition
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
64 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Control
Arm Type
No Intervention
Arm Description
The control dyad will receive usual care.
Arm Title
Intervened
Arm Type
Experimental
Arm Description
Parents receive training in problem solving skills and play therapy with their infants.
Intervention Type
Behavioral
Intervention Name(s)
Play therapy
Intervention Description
Short films that have been developed to deliver a series of child development messages will be shown at the monthly visits. Nine modules of approximate length 3 minutes each have been developed and cover the topics: Love, Comforting baby, Talking to babies and children, Praise, Using bath time to play and learn, Looking at books, Simple toys mothers can make, Drawing and games, and Puzzles. Nurses at the Sickle cell Unit (SCU) will be trained to discuss the video messages with the mothers/caregivers, demonstrate activities they can do with their children and how to make simple toys from household materials. Mothers/caregivers will practice some of the activities and they will be encouraged to make them part of their daily routine.
Intervention Type
Other
Intervention Name(s)
Problem solving skills
Intervention Description
Problem solving therapy (PST) aims to empower patients or caregivers in attending to daily challenges. It is based on cognitive behavioural therapy and can be used in primary care settings. It encourages persons to use existing resources and skills to function better and find solutions to problems. It will be delivered in 6 sessions over the 6-week period and will last for about 30 minutes per session. The stages of PST are: identification of the problems; generating possible solutions; evaluating and implementing preferred solution; and evaluating to see if the solutions were successful. The parent/caregiver will be taught a process of problem solving with reference to general everyday problems as well as specific problems which may arise while parenting a child with SCD.
Primary Outcome Measure Information:
Title
Infant's development quotient (Griffiths Developmental Scale)
Description
Griffiths Developmental Scale
Time Frame
6 months
Title
Parental stress, depression and coping (Pediatric Inventory for Parents; CES-D; Coping Health Inventory for parents)
Description
Questionnaires to assess: Pediatric Inventory for Parents; CES-D; Coping Health Inventory for parents
Time Frame
6 months
Title
Parental problem solving skills (Social Problem Solving Inventory)
Description
Using Social Problem Solving Inventory: Questionnaires
Time Frame
6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
6 Months
Maximum Age & Unit of Time
12 Months
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Infant has sickle cell disease: SS or Sβ0 thalassemia
Attending Sickle Cell Unit, Jamaica for routine care
Exclusion Criteria:
None
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jennifer Knight-Madden, MBBS, PhD
Organizational Affiliation
The University of The West Indies
Official's Role
Principal Investigator
Facility Information:
Facility Name
Sickle Cell Unit, University of West Indies, Mona Campus
City
Kingston 7
Country
Jamaica
12. IPD Sharing Statement
Learn more about this trial
Improving Parental Psychosocial Functioning and Early Developmental Outcomes in Children With Sickle Cell Disease
We'll reach out to this number within 24 hrs